Jaa DSR Capsule is a combination pharmaceutical formulation containing Domperidone 30 mg and Pantoprazole 40 mg, designed for the management of gastrointestinal disorders characterized by acid reflux and delayed gastric emptying. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility by increasing the movement of the stomach and intestines, thereby facilitating gastric emptying and reducing symptoms such as nausea and vomiting. Pantoprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, providing effective relief from acid-related conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. The synergistic action of these two active ingredients makes Jaa DSR Capsule particularly effective in treating conditions where both acid suppression and improved gastric motility are required. It is typically prescribed for patients experiencing symptoms like heartburn, regurgitation, epigastric pain, and bloating associated with acid peptic disorders. The capsule should be taken as directed by a healthcare professional, usually before meals, to optimize therapeutic outcomes. Caution is advised in patients with known hypersensitivity to either component, and it is contraindicated in those with gastrointestinal bleeding or obstruction. Regular monitoring and medical supervision are recommended during therapy.